Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Alzheimer’s disease with multimodal polypeptide-based nanoconjugates
Aroa Duro‐Castaño, Consuelo Borrás, Vicente Herranz‐Pérez, et al.
Science Advances (2021) Vol. 7, Iss. 13
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Blood-brain barrier Permeable nanoparticles for Alzheimer's disease treatment by selective mitophagy of microglia
Gang Zhong, Huiping Long, Tian Zhou, et al.
Biomaterials (2022) Vol. 288, pp. 121690-121690
Closed Access | Times Cited: 101
Multimodal Dynamics: Dynamical Fusion for Trustworthy Multimodal Classification
Zongbo Han, Fan Yang, Junzhou Huang, et al.
2022 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR) (2022), pp. 20675-20685
Closed Access | Times Cited: 70
Strategies to develop polymeric microneedles for controlled drug release
Bo Zhi Chen, Yu Ting He, Ze Qiang Zhao, et al.
Advanced Drug Delivery Reviews (2023) Vol. 203, pp. 115109-115109
Open Access | Times Cited: 55
Aβ-oligomers: A potential therapeutic target for Alzheimer's disease
Sudeshna Ghosh, Rafat Ali, Sandeep Verma
International Journal of Biological Macromolecules (2023) Vol. 239, pp. 124231-124231
Closed Access | Times Cited: 43
Precision drug delivery to the central nervous system using engineered nanoparticles
Jingjing Gao, Ziting Xia, Swetharajan Gunasekar, et al.
Nature Reviews Materials (2024) Vol. 9, Iss. 8, pp. 567-588
Closed Access | Times Cited: 29
Peptide-drug conjugates repolarize glioblastoma-associated macrophages to resensitize chemo-immunotherapy of glioblastoma
Zhi Li, Shaoping Jiang, Jie Wang, et al.
Science Advances (2025) Vol. 11, Iss. 3
Open Access | Times Cited: 2
Functionalization strategies of polymeric nanoparticles for drug delivery in Alzheimer’s disease: Current trends and future perspectives
Livia La Barbera, Emanuele Mauri, Marcello D’Amelio, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 42
Non-Enzymatic Antioxidants against Alzheimer’s Disease: Prevention, Diagnosis and Therapy
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Adelaide Carrara, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 180-180
Open Access | Times Cited: 25
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Yi Jin, Qiaofei Du, Mingjie Song, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 346-365
Closed Access | Times Cited: 10
Genistein effect on cognition in prodromal Alzheimer’s disease patients. The GENIAL clinical trial
José Viña, Joaquín Escudero, Miquel Baquero, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 37
“Drug‐Carrier” Synergy Therapy for Amyloid‐β Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly
Guochen Han, Kaiwen Bai, Xiaoyu Yang, et al.
Advanced Science (2022) Vol. 9, Iss. 14
Open Access | Times Cited: 33
Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer’s Disease
Shalini Mani, Rajni Dubey, I‐Chun Lai, et al.
Journal of Alzheimer s Disease (2023) Vol. 96, Iss. 3, pp. 877-912
Closed Access | Times Cited: 21
Targeting the central nervous system: From synthetic nanoparticles to extracellular vesicles—Focus on Alzheimer's and Parkinson's disease
Sara Hernando, Edorta Santos‐Vizcaíno, Manoli Igartúa, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Open Access | Times Cited: 19
Cascade-targeting multifunctional nanochaperone remodels brain microenvironment for synergistic therapy of Alzheimer’s disease
Xiaochen Zhang, Haodong Hu, Qiushi Li, et al.
Nano Today (2024) Vol. 55, pp. 102168-102168
Closed Access | Times Cited: 8
Human-Induced Neural and Mesenchymal Stem Cell Therapy Combined with a Curcumin Nanoconjugate as a Spinal Cord Injury Treatment
Pablo Bonilla, Joaquim Hernández, Esther Giraldo, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5966-5966
Open Access | Times Cited: 38
Multifunctional icariin and tanshinone IIA co-delivery liposomes with potential application for Alzheimer’s disease
Jiao Wang, Liang Kong, Rui-bo Guo, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1648-1662
Open Access | Times Cited: 25
Conjugation, Prodrug, and Co-Administration Strategies in Support of Nanotechnologies to Improve the Therapeutic Efficacy of Phytochemicals in the Central Nervous System
Giovanna Rassu, Milena Sorrenti, Laura Catenacci, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1578-1578
Open Access | Times Cited: 12
Propargylamine: an Important Moiety in Drug Discovery
Aitor Carneiro, Eugenio Uriarte, Fernanda Borges, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 2, pp. 211-224
Closed Access | Times Cited: 11
Multi-Level Confidence Learning for Trustworthy Multimodal Classification
Xiao Zheng, Chang Tang, Zhiguo Wan, et al.
Proceedings of the AAAI Conference on Artificial Intelligence (2023) Vol. 37, Iss. 9, pp. 11381-11389
Open Access | Times Cited: 11
Polymer–drug conjugates as nano-sized multi-targeting systems for the treatment of Alzheimer's disease
Nuruddin Mahadik, Gemma A. Barron, Paul Kong Thoo Lin, et al.
RSC Pharmaceutics (2024) Vol. 1, Iss. 2, pp. 161-181
Open Access | Times Cited: 4
Nanoscale drug formulations for the treatment of Alzheimer's disease progression
Liu Liqin, Haini He, Bert N. La Du, et al.
RSC Advances (2025) Vol. 15, Iss. 6, pp. 4031-4078
Open Access
Off‐The‐Shelf Multivalent Nanoconjugate Cancer Vaccine Rescues Host Immune Response against Melanoma
Liane I.F. Moura, Alessio Malfanti, Ana I. Matos, et al.
Advanced Materials (2025)
Open Access
Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood–brain barrier model
Mária Mészáros, Thi Ha My Phan, Judit P. Vigh, et al.
Fluids and Barriers of the CNS (2025) Vol. 22, Iss. 1
Open Access
Review of recent preclinical and clinical research on ligand-targeted liposomes as delivery systems in triple negative breast cancer therapy
Mohammad Hajimolaali, Farid Abedin Dorkoosh, Sophia G. Antimisiaris
Journal of Liposome Research (2024) Vol. 34, Iss. 4, pp. 671-696
Closed Access | Times Cited: 3
Polymer-Drug Conjugates
Chiara Fante, Marı́a J. Vicent, Francesca Greco
(2024), pp. 109-137
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top